MARCHI, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 640
NA - Nord America 595
AS - Asia 170
AF - Africa 1
Totale 1.406
Nazione #
US - Stati Uniti d'America 595
RU - Federazione Russa 295
PL - Polonia 108
IT - Italia 86
SG - Singapore 63
IE - Irlanda 59
SE - Svezia 50
HK - Hong Kong 38
CN - Cina 33
IN - India 20
DE - Germania 11
JO - Giordania 10
GB - Regno Unito 9
DK - Danimarca 7
FI - Finlandia 4
VN - Vietnam 4
ES - Italia 3
UA - Ucraina 3
CH - Svizzera 2
NL - Olanda 2
BY - Bielorussia 1
CI - Costa d'Avorio 1
JP - Giappone 1
KR - Corea 1
Totale 1.406
Città #
Santa Clara 158
Warsaw 108
Dublin 59
Chandler 58
Singapore 53
Fairfield 52
Ashburn 36
Moscow 27
Florence 24
Hong Kong 24
Mumbai 19
Lawrence 18
Altamura 17
Woodbridge 17
Seattle 15
Wilmington 15
New York 14
Cambridge 13
Houston 13
Shanghai 12
Los Angeles 11
Princeton 11
Ann Arbor 9
Buffalo 9
Medford 8
Alghero 7
Beijing 7
Boston 7
Copenhagen 7
Munich 7
Prato 7
Boardman 5
Kent 5
Naples 5
Changsha 4
Dong Ket 4
Bilbao 3
Lappeenranta 3
San Diego 3
Yubileyny 3
Bagno a Ripoli 2
Bern 2
Bologna 2
Falls Church 2
Kilburn 2
Lecce 2
Lodi 2
London 2
Wuhan 2
Abidjan 1
Amsterdam 1
Andover 1
Anguillara Sabazia 1
Arezzo 1
Chennai 1
Clifton 1
Guangzhou 1
Helsinki 1
Hillsboro 1
Norwalk 1
Phoenix 1
Rome 1
Rui'an 1
San Miniato Basso 1
Sapporo 1
Seoul 1
Southwark 1
Staranzano 1
Tavarnuzze 1
Viterbo 1
Wandsworth 1
Washington 1
Totale 918
Nome #
Muscle shortening maneuver and not topical anti-inflammatory therapy is effective in reducing the width of subacromial-subdeltoid bursa in shoulder impingement syndrome 207
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 132
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 107
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 97
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging 96
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 89
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 87
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 81
Antiarrhythmic efficacy of anakinra in a young patient with autoimmune lymphocytic myocarditis 78
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 69
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 61
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 56
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care 54
Stage-specific therapy for hypertrophic cardiomyopathy 54
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 51
Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama 37
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 37
Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy 34
Totale 1.427
Categoria #
all - tutte 5.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.533


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202091 0 0 0 0 8 13 14 16 13 9 13 5
2020/2021146 8 12 0 31 16 9 7 7 24 10 13 9
2021/202291 5 0 1 4 2 14 0 3 9 8 16 29
2022/2023270 19 64 19 10 17 42 39 14 29 7 3 7
2023/2024188 8 11 20 10 21 24 15 35 4 19 14 7
2024/2025609 34 129 63 171 212 0 0 0 0 0 0 0
Totale 1.427